Company Filing History:
8 out of 31 
4 out of 4 
1 out of 1 Years Active: 1995-2015
Title: The Innovative Contributions of Mark Pines to Skeletal Muscle Research
Introduction: Mark Pines, a prominent inventor based in Rehovot, Israel, has made significant strides in the field of medical research, particularly concerning skeletal muscle fibrosis. With a total of 14 patents to his name, Pines has proven to be a vital contributor to advancements in biomedical science.
Latest Patents: Among Mark Pines' most recent innovations is a groundbreaking composition and method for treating or preventing skeletal muscle fibrosis. This patent describes a compound that combines with a pharmaceutically acceptable carrier, featuring a complex chemical formula that outlines various substituents such as hydrogen, halogen, nitro, and lower alkyl groups. The invention aims to provide treatment options for individuals suffering from skeletal muscle fibrosis and promote skeletal muscle regeneration.
Career Highlights: Throughout his career, Pines has worked with esteemed organizations, including Hadasit Medical Research Services and Development Company and the Agricultural Research Organization under the Ministry of Agriculture. His expertise and innovative mindset have led to advancements in treating chronic conditions related to skeletal muscle.
Collaborations: Mark Pines has collaborated with notable coworkers like Arnon Nagler and Israel Vlodavsky, who have contributed to his research efforts. These partnerships have further enriched the scope and applicability of his inventions, fostering an environment of scientific progress.
Conclusion: Mark Pines stands out as a key figure in the realm of medical innovation, demonstrating a steadfast commitment to advancing therapeutic techniques for muscle-related disorders. With his wealth of patents and collaborative spirit, Pines continues to influence the future of medical research and treatment methodologies.